---
title: TRC Healthcare | Insights Newsletter January 2026
description: Get the top Letter articles forJanuary, don't miss our upcoming live CE webinars, explore popular clinical resources, and more!
---

[![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos%202022/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://trchealthcare.com/category/resources/)

[![Insights: Emerging Trends for Clinical Leadership](https://info.trchealthcare.com/hs-fs/hubfs/trc_Insights_1300x300_text.png?width=1300&height=300&name=trc_Insights_1300x300_text.png) ](https://trchealthcare.com/insights-newsletter-january-2026-emerging-trends-for-clinical-leadership/)

**January 2026**

### Updates You Don't Want Your Team to Miss

 Address New GLP-1 Agonist Side Effect Concerns ** **

Your team will need to be prepared to answer questions about whether recent side effect claims about GLP-1 agonists are true. Our articles analyze claims about whether GLP-1s are linked with hair loss, erectile dysfunction, or suicide. We also sort out whether GLP-1 agonists should be stopped prior to surgery due to aspiration risk. Readers can also [listen to](https://pharmacist.therapeuticresearch.com/Site/Podcasts) or [watch](https://www.youtube.com/playlist?list=PL3NwGSHuwBrtb4s9M6rs_rW-S5gb_rXs2) our latest *Rumor vs Truth *podcast, where our editors dive deeper into the evidence about GLP-1 side effect claims.   

**Read More**:  

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Jan/Address-New-Side-Effect-Concerns-Around-GLP-1-Agonists) 
- [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Jan/Listen-for-New-Side-Effect-Concerns-With-GLP-1-Agonists) 
- [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Jan/Address-New-GLP-1-Agonist-Side-Effect-Concerns) 
- [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Articles/PLC/2026/Jan/Address-New-GLP-1-Agonist-Side-Effect-Concerns) 
- [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Jan/Listen-for-New-Side-Effect-Concerns-With-GLP-1-Agonists) 
- [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Articles/PTLC/2026/Jan/Listen-for-New-Side-Effect-Concerns-With-GLP-1-Agonists) 
- [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2026/Jan/Address-New-GLP-1-Agonist-Side-Effect-Concerns) 

 Community Pharmacies: Point Out Caveats With Direct-to-Consumer Meds ** **

Your staff will need to understand and explain the nuances of direct-to-consumer (DTC) Rx programs. Our articles point out pros and cons, including that DTC programs may not always lead to big savings.  We also discuss other considerations with DTC programs such as the need for increased vigilance when updating patient med lists. Readers can use our [*Guide for Helping Patients Afford Their Meds*](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Jun/Guide-for-Helping-Patients-Afford-Their-Medications-8526) to help patients use cost-effective meds right off the bat instead of jumping to a DTC Rx option. 

**Read More**: 

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Jan/Ask-About-Direct-to-Consumer-Rxs-During-Med-Histories) 
- [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Jan/Ask-About-Direct-to-Consumer-Rxs-During-Med-Histories) 
- [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Jan/Point-Out-Caveats-With-Direct-to-Consumer-Meds) 
- [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Jan/Point-Out-Caveats-With-Direct-to-Consumer-Meds) 
- [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2026/Jan/Point-Out-Caveats-With-Direct-to-Consumer-Meds) 

 Hospitals: Have a Plan When It Comes to Hazardous Med Spills ** **

Your team can help prevent dangerous exposures from hazardous drug spills. Our articles discuss a practical approach to remember the steps to address a spill and gives best practices for spill kit contents.  We also review what to do if a team member comes in direct contact with a hazardous med, as well as ways to prevent spills. Readers can refer to our [*Handling Hazardous Meds*](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2016/Feb/Handling-Hazardous-Meds-9420)* *resource for more on cleaning requirements, assessment of risk, and personal protective equipment. 

**Read More**:  

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Jan/Have-a-Plan-When-It-Comes-to-Hazardous-Med-Spills) 
- [Hospital Pharmacy Technician's Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Jan/Have-a-Plan-When-It-Comes-to-Hazardous-Med-Spills) 

### Natural Medicines

[![GLP-1 ](https://info.trchealthcare.com/hs-fs/hubfs/GLP-1%20%20X.png?width=1600&height=900&name=GLP-1%20%20X.png) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/January2026/Beyond-Weight-Loss-GLP-1-RA-Nutritional-Considerations?_gl=1*14yj04z*_gcl_au*MTQwNjgxNTU3OC4xNzYyOTIzNjQx*_ga*MTg0NDQ3NDYyLjE3NDcwNjY0ODI.*_ga_89300NMX1V*czE3NjgzMzk4NDkkbzEyNiRnMCR0MTc2ODMzOTg0OSRqNjAkbDAkaDA.&_ga=2.196500719.2112076579.1768244253-184447462.1747066482&pk_vid=4aeba5d2a906b23417683578068be310)

### **Beyond Weight Loss: GLP-1 RA Nutritional Considerations** 

Patients using GLP-1 receptor agonists (GLP-1 RA), such as semaglutide or tirzepatide, for weight loss may experience undesired effects including loss of muscle mass and nutrient deficiencies. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/January2026/Beyond-Weight-Loss-GLP-1-RA-Nutritional-Considerations) provides practical strategies to help patients maintain muscle mass while using a GLP-1 RA. For instance, we suggest boosting protein intake, such as up to 1.5 g/kg/day for physically active adults on a GLP-1 RA, and including regular strength training as part of the physical activity regimen. We also provide guidance about dietary strategies and the role of supplements to avoid nutrient deficiencies while on a GLP-1 RA. 

[![GLP-1 ](https://info.trchealthcare.com/hs-fs/hubfs/GLP-1%20%20X.png?width=1600&height=900&name=GLP-1%20%20X.png) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/January2026/Beyond-Weight-Loss-GLP-1-RA-Nutritional-Considerations?_gl=1*14yj04z*_gcl_au*MTQwNjgxNTU3OC4xNzYyOTIzNjQx*_ga*MTg0NDQ3NDYyLjE3NDcwNjY0ODI.*_ga_89300NMX1V*czE3NjgzMzk4NDkkbzEyNiRnMCR0MTc2ODMzOTg0OSRqNjAkbDAkaDA.&_ga=2.196500719.2112076579.1768244253-184447462.1747066482&pk_vid=4aeba5d2a906b23417683578068be310)

### **Beyond Weight Loss: GLP-1 RA Nutritional Considerations** 

Patients using GLP-1 receptor agonists (GLP-1 RA), such as semaglutide or tirzepatide, for weight loss may experience undesired effects including loss of muscle mass and nutrient deficiencies. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/January2026/Beyond-Weight-Loss-GLP-1-RA-Nutritional-Considerations) provides practical strategies to help patients maintain muscle mass while using a GLP-1 RA. For instance, we suggest boosting protein intake, such as up to 1.5 g/kg/day for physically active adults on a GLP-1 RA, and including regular strength training as part of the physical activity regimen. We also provide guidance about dietary strategies and the role of supplements to avoid nutrient deficiencies while on a GLP-1 RA. 

### Pharmacy and Prescriber Podcasts

#### Medication Talk

Listen to this month’s podcast episode, [*Smoking and Vaping Cessation*](https://trchealthcare.buzzsprout.com/1968313/episodes/18378042-smoking-and-vaping-cessation), as our expert panel discusses evidence-based approaches to help patients quit smoking, vaping, and using other nicotine products. You’ll gain practical insights on medication selection, combination strategies, and tailored approaches for helping patients break free from nicotine addiction. 

All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses.  

![medication talk on phone with headphones ](https://info.trchealthcare.com/hs-fs/hubfs/medication%20talk%20on%20phone%20with%20headphones%20.png?width=1081&height=712&name=medication%20talk%20on%20phone%20with%20headphones%20.png)

#### Rumor vs Truth

[Listen to](https://trchealthcare.com/rumor-vs-truth-glp-1-side-effects/) or [watch](https://www.youtube.com/watch?v=GgAh44dbNw0) the latest episode, *GLP-1 Side Effects*, as hosts Don and Steve dig into the evidence behind the most talked-about risks of GLP-1 agonists, separating clinical truth from rumors and headlines. 

We’re excited to share that Rumor vs Truth podcast episodes now offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses. 

#### Clinical Capsules

Listen to our latest episode, [Preventing Respiratory Syncytial Virus (RSV): Immunization Updates](https://trchealthcare.com/clinical-capsules-preventing-respiratory-syncytial-virus-rsv-immunization-updates/), as Associate Editor, Vickie Danaher, PharmD, reviews who should receive RSV vaccines, recent changes to age and risk-based recommendations, and how monoclonal antibodies protect infants and high-risk children.

We’re excited to share that Clinical Capsules podcast episodes now offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses. 

### Upcoming Live CE Webinars for Your Clinicians

#### Antimicrobial Stewardship: Putting Principles into Practice

**Dates: January 3 and 15, 2025**

In this month's live webinar, [*Antimicrobial Stewardship: Putting Principles into Practice*](https://learning.therapeuticresearch.com/course/view.php?id=7001), you'll hear our panelists review important concepts to help decrease antibiotic resistance. And you'll listen as our panelists share their practical approaches on how to limit unnecessary antimicrobial use.         
   
Submit your questions [here](https://forms.office.com/r/PDp3ezPWUX) for a chance to have them answered during the webinar. 

Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME: 

- ACCME: 1.00 hour 
- ACPE: 1.00 hour – pharmacists and technicians 
- ANCC: 1.00 hour 

[![Register Now](https://no-cache.hubspot.com/cta/default/229441/92554205-0d82-4fb6-89e7-c09b12d0d71e.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/92554205-0d82-4fb6-89e7-c09b12d0d71e)

#### Pharmacy Essential Updates 

**Upcoming 2026 Live Webinars  
**Check out our upcoming [Pharmacy Essential live CE webinars](https://learning.therapeuticresearch.com/local/webinar/reports/upcoming_webinars.php). Topics include: 

**January  **

- Male pattern hair loss 
- KIDS list updates 
- NatMed Spotlight: methylene blue 

*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar. 

[![View Live CE Webinars](https://no-cache.hubspot.com/cta/default/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79)

### Popular Clinical Resources

 GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart ** **

Our new interactive chart allows you to customize a view of these meds to compare dosing and titration, approximate A1c decrease and weight reduction, clinical outcomes, available strengths, and more.  We also provide guidance on comparative dosing amongst products to help with switches. 

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 
- [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2025/May/GLP-1-and-GIP-GLP-1-Receptor-Agonist-Interactive-Comparison-Chart-S2505002) 

 Pharmacotherapy of Acne ** **

Use our updated resource as a quick reference to available products, formulations, and estimated cost. 

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Inhalation-Medications-for-Asthma-US-7837) 
- [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Inhalation-Medications-for-Asthma-US-7837) 
- [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Inhalation-Medications-for-Asthma-US-7837) 
- [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Dec/Inhalation-Medications-for-Asthma-Canada-S2512002) 
- [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Inhalation-Medications-for-Asthma-US-7837) 
- [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Dec/Inhalation-Medications-for-Asthma-Canada-S2512002) 
- [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Inhalation-Medications-for-Asthma-US-7837) 

 Stepwise Treatment of Asthma (12 Years and Older) and Stepwise Treatment of Asthma (Under 12 Years of Age) ** **

Post our new algorithms to ensure patients are started on appropriate treatment, for guidance about stepping up therapy, and to get help with steroid and combo product dosing.

- Hospital Pharmacist’s Letter  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Hospital Pharmacy Technician’s Letter  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Pharmacist’s Letter  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Pharmacist’s Letter Canada  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Pharmacy Technician’s Letter  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Pharmacy Technician’s Letter Canada  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

- Prescriber Insights  
    - [Stepwise Treatment of Asthma (12 Years and Older)](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2014/Dec/Stepwise-Treatment-of-Asthma-12-years-and-older-7836) 
    - [Stepwise Treatment of Asthma (Under 12 Years of Age)](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2018/Apr/Stepwise-Treatment-of-Asthma-Under-12-years-of-Age-12123) 

 Potentially Harmful Drugs in Children ** **

Refer to our updated chart for a listing of potentially unsafe or inappropriate drugs and excipients in pediatric patients along with alternatives. 

- [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 
- [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2020/Aug/Potentially-Harmful-Drugs-in-Children-S2008002) 

[![dog at the vet](https://info.trchealthcare.com/hs-fs/hubfs/Jan-26-CC-Blog-Image-e1768237601351.png?width=649&height=775&name=Jan-26-CC-Blog-Image-e1768237601351.png) ](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/)

#### The Compounding Chronicles

**USP <800> Isn’t Just for Pharmacies—Here’s Who’s Still at Risk**

*By Adam West, Course and Curriculum Manager at [CriticalPoint](https://trchealthcare.com/criticalpoint/)*

Veterinary oncology clinics face unique hazardous drug safety challenges. This month, [The Compounding Chronicles](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/) reveal how gaps in awareness, training, and containment can impact staff and pet safety and why USP <800> matters beyond traditional pharmacy settings.

[Read the Blog](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/)

[![dog at the vet](https://info.trchealthcare.com/hs-fs/hubfs/Jan-26-CC-Blog-Image-e1768237601351.png?width=649&height=775&name=Jan-26-CC-Blog-Image-e1768237601351.png) ](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/)

#### The Compounding Chronicles

**USP <800> Isn’t Just for Pharmacies—Here’s Who’s Still at Risk**

*By Adam West, Course and Curriculum Manager at [CriticalPoint](https://trchealthcare.com/criticalpoint/)*

Veterinary oncology clinics face unique hazardous drug safety challenges. This month, [The Compounding Chronicles](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/) reveal how gaps in awareness, training, and containment can impact staff and pet safety and why USP <800> matters beyond traditional pharmacy settings.

[Read the Blog](https://trchealthcare.com/the-compounding-chronicles-usp-isnt-just-for-pharmacies-heres-whos-still-at-risk/)

#### Product Spotlight

As the new year begins, now is the perfect time to shore up your compounding practices for 2026, before gaps become risks. Evolving USP <795>, <797>, and <800> standards demand precision, yet many organizations still face fragmented training, inconsistent SOPs, and limited visibility into staff readiness. Without a unified approach, it becomes increasingly difficult to maintain consistency, reduce risk, and stay inspection-ready across every location and shift.  

[**TRC Healthcare's Compounding Compliance Suite**](https://info.trchealthcare.com/pharmacy-workforce-suite) simplifies the process and helps you:  

- Deliver standardized, expert-led training across roles and sites  
- Align with USP standards using CriticalPoint’s trusted education  
- Prepare technicians for CSPT certification with targeted prep tools  
- Monitor training progress and generate audit-ready reports with ease  
- Build compliant workflows that support 340B oversight and beyond 

Whether you're onboarding new staff or reinforcing best practices, this suite gives you the structure and support to build a confident, compliant compounding program, without the administrative burden. 

[![Learn More](https://no-cache.hubspot.com/cta/default/229441/d9f89d74-5b30-45c0-8c79-39b1d6337b2e.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/d9f89d74-5b30-45c0-8c79-39b1d6337b2e)

 

![TRC Healthcare](https://info.trchealthcare.com/hs-fs/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20EM.png?width=860&height=260&name=TRC%20Logo%20-%20EM.png)

##### **Free Live Webinar: From Education Vendor to Workforce Partner: Introducing TRC Healthcare’s Pharmacy Workforce Solutions**

Join us on January 28 at 3:00 p.m. ET for a webinar introducing TRC Healthcare’s new Pharmacy Workforce Solutions—a unified, role-based approach to developing your entire pharmacy team to achieve your specific business goals. 

Can’t attend live? Register anyway and we’ll send you the recording. 

[ Register Now ](https://info.trchealthcare.com/solutions-pharmacy-workforce-b2b-webinar-0126)

### About TRC Healthcare

###### TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes.

![](https://info.trchealthcare.com/hubfs/raw_assets/public/TRC/Images/logoIcon.svg)

- [ Contact Us ](https://trchealthcare.com/contact-us/)
- [ Privacy Policy ](https://info.trchealthcare.com/data-usage-policy)

[![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://www.trchealthcare.com)

 © 2026 TRC Healthcare. All Rights Reserved.